Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Toxicology Letters|February 22, 2011
Drug-drug interactions by azole antifungals: Beyond a dogma of CYP3A4 enzyme activity inhibitionZdenek DvorakExpert Opinion on Drug Metabolism & Toxicology|November 28, 2015
Opportunities and challenges in using human hepatocytes in cytochromes P450 induction assaysZdenek DvorakFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 12, 2012
Effects of flavored mineral waters on AhR-CYP1A1 signaling pathway in primary human hepatocytes and in human hepatic and intestinal cancer cellsAlzbeta Kamenickova, Zdenek DvorakDrug Discovery Today|June 27, 2008
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?Boris Cvek, Zdenek DvorakCurrent Drug Metabolism|March 15, 2011
Steroid regulation of drug-metabolizing cytochromes P450Katalin Monostory, Zdenek DvorakDrug Metabolism Reviews|May 21, 2010
Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoidsZdenek Dvorak, Peotr PavekCurrent Drug Metabolism|March 16, 2011
Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome p450 enzymesJulius Brtko, Zdenek DvorakBiochimie|October 4, 2020
Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor actionJulius Brtko, Zdenek DvorakPlos One|August 21, 2014
Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axisAneta Novotna, Zdenek DvorakFundamental & Clinical Pharmacology|July 15, 2016
The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytesRadim Vrzal, Zdenek DvorakPageof 10